These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 946632)

  • 21. Therapy of lipid disorders.
    Krikler DM
    J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():72-7. PubMed ID: 4582173
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of the hyperlipoproteinemias.
    Bagdade JD
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():98-110. PubMed ID: 4605376
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
    Crepaldi G; Fellin R; Briani G
    Adv Exp Med Biol; 1973; 38():199-217. PubMed ID: 4766527
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of the hyperlipidaemias.
    Drug Ther Bull; 1980 Mar; 18(7):25-8. PubMed ID: 7371502
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug therapy of hypercholesterinemias (author's transl)].
    Canzler H
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):464-70. PubMed ID: 6769018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of hyperlipidemic states.
    Strisower EH; Adamson G; Strisower B
    Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683
    [No Abstract]   [Full Text] [Related]  

  • 29. Dextrothyroxine for lowering cholesterol.
    Med Lett Drugs Ther; 1976 Jun; 18(13):53. PubMed ID: 934018
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug treatment of hyperlipidemia.
    Samuel P
    Am Heart J; 1980 Oct; 100(4):573-7. PubMed ID: 7415943
    [No Abstract]   [Full Text] [Related]  

  • 31. Classification of hyperlipidaemias.
    Lewis B
    Proc R Soc Med; 1971 Sep; 64(9):905-8. PubMed ID: 5114287
    [No Abstract]   [Full Text] [Related]  

  • 32. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
    Casdorph HR
    Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lowering lipids rapidly and permanently with etofibrate].
    von Bock und Polach U
    Med Klin; 1982 Jan; 77(3):35-8. PubMed ID: 7057729
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of hypolipidemic drugs on plasma lipoproteins.
    Levy RI
    Annu Rev Pharmacol Toxicol; 1977; 17():499-510. PubMed ID: 326171
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hyperlipoproteinemia type II].
    Schade RW
    Ned Tijdschr Geneeskd; 1980 Dec; 124(51):2172-81. PubMed ID: 6782494
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug treatment of hyperlipoproteinemias].
    Hanefeld M
    Z Gesamte Inn Med; 1977 May; 32(9):139-43. PubMed ID: 906593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipoproteinemia and atherosclerosis as a problem for the pediatrician].
    Turcanu L; Micle I; Tomoşoiu O
    Rev Pediatr Obstet Ginecol Pediatr; 1975; 24(2):105-14. PubMed ID: 810851
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of coronary heart disease with diet and lipid-reducing agents].
    Sailer D; Kolb S
    Fortschr Med; 1982 Nov; 100(43):2005-10. PubMed ID: 7152437
    [No Abstract]   [Full Text] [Related]  

  • 40. Control of biochemical precursors of coronary heart disease.
    Ostrander LD
    Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.